Literature DB >> 14986830

Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland.

H Janiszewska1, O Haus, A Lauda-Swieciak, M Pasińska, R Laskowski, W Szymański, B Górski, J Lubiński.   

Abstract

A group of 63 families from the Pomerania-Kujawy region were analyzed for three BRCA1 gene Polish founder mutations, 5382insC, 300T>G, and 4153delA, because of breast (BrCa) and/or ovarian cancer (OvCa) history. The analysis was carried out by multiplex polymerase chain reaction method. BRCA1 mutation was revealed in nine (14%) families: in three (33%) of hereditary BrCa and OvCa families, in three (8%) of hereditary BrCa families, and in three (21%) of hereditary OvCa families. According to risk criteria, it was revealed in 45% of high-risk families with more than three cancers, 13% of moderate-risk families with two cancers, and 8% of families with sporadic OvCa. In six families, the mutation was found in a proband with BrCa or OvCa and in three families, the mutation was found in a healthy proband, first-degree relative of a patient deceased of BrCa or OvCa. 5382insC frameshift mutation accounted for 67% and 300T>G missense mutation for 33% of all identified familial mutations. 4153delA frameshift mutation was not found in analyzed sample of families. 5382insC mutation was found in 9% and 300T>G in 5% of all investigated families, and in 27 and 18%, respectively, of high-risk families. This underlines the importance of applying strict inclusion criteria to analyze mutation frequency in hereditary BrCa/OvCa families.

Entities:  

Mesh:

Year:  2003        PMID: 14986830     DOI: 10.1046/j.1399-0004.2003.00178.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

Review 1.  Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.

Authors:  Furu Wang; Qiaoqiao Fang; Zhen Ge; Ningle Yu; Sanxiao Xu; Xiangyong Fan
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

2.  Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.

Authors:  Lucian Negura; Nancy Uhrhammer; Anca Negura; Vlad Artenie; Eugen Carasevici; Yves-Jean Bignon
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.

Authors:  Izabela Brozek; Magdalena Ratajska; Magdalena Piatkowska; Anna Kluska; Aneta Balabas; Michalina Dabrowska; Dorota Nowakowska; Anna Niwinska; Jadwiga Rachtan; Jan Steffen; Janusz Limon
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  [Adequate system for investigation of translation initiation of the human retrotransposon L1 mRNA in vitro].

Authors:  S E Dmitriev; N V Bykova; D E Andreev; I M Terenin
Journal:  Mol Biol (Mosk)       Date:  2006 Jan-Feb

5.  Prevalence of the most frequent BRCA1 mutations in Polish population.

Authors:  Izabela Brozek; Celina Cybulska; Magdalena Ratajska; Magdalena Piatkowska; Anna Kluska; Aneta Balabas; Michalina Dabrowska; Dorota Nowakowska; Anna Niwinska; Jolanta Pamula-Pilat; Karolina Tecza; Wioletta Pekala; Jolanta Rembowska; Karina Nowicka; Maria Mosor; Danuta Januszkiewicz-Lewandowska; Jadwiga Rachtan; Ewa Grzybowska; Jerzy Nowak; Jan Steffen; Janusz Limon
Journal:  J Appl Genet       Date:  2011-04-19       Impact factor: 3.240

6.  Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.

Authors:  Bohdan Górski
Journal:  Hered Cancer Clin Pract       Date:  2006-08-15       Impact factor: 2.857

7.  Selected aspects of genetic counselling for BRCA1 mutation carriers.

Authors:  Jacek Gronwald
Journal:  Hered Cancer Clin Pract       Date:  2007-03-15       Impact factor: 2.857

8.  Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country.

Authors:  Martyna Hartwig; Hanna Janiszewska; Aneta Bąk; Maria Pilarska; Marta Heise; Anna Junkiert-Czarnecka; Ryszard Laskowski; Olga Haus
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

9.  Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

Authors:  Mateja Krajc; Erik Teugels; Janez Zgajnar; Guido Goelen; Nikola Besic; Srdjan Novakovic; Marko Hocevar; Jacques De Grève
Journal:  BMC Med Genet       Date:  2008-09-10       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.